Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Is there a plan behind?

scenario 2 opty, one could say if his interest in the mmp is small enough, then the value is not that big.

however, since we do not know if there is an advantage to ptsc re. master agreement, and potential change of ownership, or buy out of ownership, leckrone still has controll about the commercialization of the mmp.

this controll still is a big one, depending on potential revenue shares in case of success.

and still the question remains open, what was then the advantage to moore, may be he is one very big ptsc shareholder by now?

Share
New Message
Please login to post a reply